Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice

  • Ikuko Takahara,
  • Yuko Akazawa,
  • Maiko Tabuchi,
  • Katsuya Matsuda,
  • Hisamitsu Miyaaki,
  • Youko Kido,
  • Yasuko Kanda,
  • Naota Taura,
  • Ken Ohnita,
  • Fuminao Takeshima,
  • Yusuke Sakai,
  • Susumu Eguchi,
  • Masahiro Nakashima,
  • Kazuhiko Nakao

There is an error in affiliation 1 for authors Ikuko Takahara, Yuko Akazawa, Maiko Tabuchi, Hisamitsu Miyaaki, Youko Kido, Yasuko Kanda, Naota Taura, Ken Ohnita, Fuminao Takeshima, and Kazuhiko Nakao. The correct affiliation 1 is: Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Reference

  1. 1. Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, et al. (2017) Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS ONE 12(3): e0170591. https://doi.org/10.1371/journal.pone.0170591 pmid:28278289

Citation: Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, et al. (2020) Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS ONE 15(7): e0235729. https://doi.org/10.1371/journal.pone.0235729

Published: July 1, 2020

Copyright: © 2020 Takahara et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.